[Federal Register Volume 70, Number 101 (Thursday, May 26, 2005)]
[Notices]
[Pages 30474-30475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-10533]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of the Director; 
Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the inaugural 
meeting of the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
federal oversight of usual-use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public as indicated below. Pre-
registration is recommended due to space limitations. Persons planning 
to attend should register online at http://www.biosecurityboard.gov/meeting.asp or by calling The Hill Group (Heather Thompson) at 301-897-
2789, ext. 132. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should indicate these requirements upon registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: June 30-July 1, 2005.
    Open: 8 a.m. to 3 p.m.
    Agenda: (1) Presentation and discussions on criteria for 
defining dual-use research in the life sciences and the role of a 
code of conduct for the life sciences; (2) discuss issues raised by 
dual-use research with respect to scientific communication, genome 
synthesis, and international perspectives; (3) public comments; (4) 
and other business of the committee.
    Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, 
Maryland.
    Contact Person: Thomas Holohan, M.D., NSABB Executive Director, 
6705 Rockledge Drive, Bethesda, Maryland 20892. (301) 496-9838.
    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the webcast and pre-registration, will be available at http://www.biosecurityboard.gov.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization

[[Page 30475]]

represented and a short description of the oral presentation. Only 
one representative of an organization may be allowed to present oral 
comments if accepted by the committee. Both printed and electronic 
copies are requested for the record. In addition, any interested 
person may file written comments with the committee. All written 
comments must be received by June 17, 2005 and should be sent via e-
mail to [email protected] with ``NSABB Public Comment'' as the 
subject line or by regular mail to 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892, Attention Dr. Ansalan Stewart. The statement 
should include the name, address, telephone number and, when 
applicable, the business or professional affiliation of the 
interested person.

    Dated: May 18, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10533 Filed 5-25-05; 8:45 am]
BILLING CODE 4140-01-M